Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer-Reference-Cited by-同舟云学术

Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer

Published:2008-01 Issue:3 Volume:47 Page:337-346
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Sgouros Joseph,Maraveyas Anthony

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860701687267

Reference35 articles.

1. Locally Advanced Pancreatic Cancer: Current Therapeutic Approach

2. 13-cis-Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Report of a Pilot Phase II Study

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

4. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records;eLife;2023-11-21

2. Survival Outcomes after Placement of Inferior Vena Cava Filters in Cancer Patients: Insights from a Comprehensive Cancer Center’s Experience;Journal of Clinical Medicine;2023-11-21

3. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments;Current Oncology;2023-08-02

4. Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records;2023-02-16

5. Risk of early death in adolescents and young adults with cancer: a population-based study;JNCI: Journal of the National Cancer Institute;2023-01-23